BTMD | tickerfilter.com

Fundamental analysis

48%

Profitability 38%

Dept financing 33%

Liquidity 7%

Performance 73%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

1.18%

3 Months

-40.24%

6 Months

-34.54%

1 Year

-37.41%

2 Year

-46.90%

Key data

Stock price

$3.43

P/E Ratio

106.37

DAY RANGE

$3.35 - $3.46

EPS

$0.61

52 WEEK RANGE

$3.04 - $8.44

52 WEEK CHANGE

-$37.41

MARKET CAP

335.804 M

YIELD

N/A

SHARES OUTSTANDING

32.581 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-06-2025

BETA

1.02

PUBLIC FLOAT

AVERAGE 10 VOLUME

$75,035

AVERAGE 30 VOLUME

$152,434

Company detail

CEO: Terry S. Weber
Region: US
Website: biote.com
Employees: 0
IPO year: 2021

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.

BTMD - biote Corp.